EDWARD WHOLIHAN
CIK 1719764 · Chief Financial Officer · last filed 2026-04-01
EDWARD WHOLIHAN is a Chief Financial Officer who has filed 17 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing shows the insider was granted $15.0K of KRMD on Apr 1, 2026. Across all open-market trades the lifetime net is −$93.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $191.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$191.0K
2
17
-$93.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRMD | Director | 47,741 | $4.00 | $191.0K | $0 | 11 | 2026-04-01 |
| Allena Pharmaceuticals, Inc. (ALNA) Delisted | Chief Financial Officer | 189,822 | $0.07 | $14.2K | -$93.2K | 6 | 2020-12-18 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-01 | KRMD | Grant (A) | +3,472 | $15.0K | EDGAR |
| 2026-01-02 | KRMD | Grant (A) | +2,581 | $15.0K | EDGAR |
| 2025-10-02 | KRMD | Grant (A) | +3,916 | $15.0K | EDGAR |
| 2025-07-02 | KRMD | Grant (A) | +4,189 | $15.0K | EDGAR |
| 2025-04-02 | KRMD | Grant (A) | +5,870 | $15.0K | EDGAR |
| 2025-01-03 | KRMD | Grant (A) | +3,937 | $15.0K | EDGAR |
| 2024-10-01 | KRMD | Grant (A) | +5,454 | $15.0K | EDGAR |
| 2024-07-12 | KRMD | Grant (A) | +5,545 | $15.0K | EDGAR |
| 2024-04-01 | KRMD | Grant (A) | +6,329 | $15.0K | EDGAR |
| 2024-01-02 | KRMD | Grant (A) | +6,329 | $15.0K | EDGAR |